It is a renaissance for companies that sell GPU-dense systems and low-power clusters that are right for handling AI inference workloads, especially as they look to the healthcare market–one that for a ...

AI in Pathology Market OverviewThe global AI in pathology market is anticipated to witness robust expansion, growing at an ...

Pathology laboratories are big data environments. However, these big data are often hidden behind expert humans who manually and with great care visually parse large complex and detailed datasets to ...

Human tissue is intricate, complex and, of course, three dimensional. But the thin slices of tissue that pathologists most often use to diagnose disease are two dimensional, offering only a limited ...

Rare diseases are often difficult to diagnose and predicting the best course of treatment can be challenging for clinicians. Investigators from the Mahmood Lab at Brigham and Women's Hospital, a ...

Digital Pathology Market OverviewThe global digital pathology market is projected to grow at a robust compound annual growth rate of approximately 10.5% through 2029, driven by rapid technological ...

Rare tumors, although individually uncommon, collectively account for a considerable proportion of cancer diagnoses and pose unique clinical and biological ...

Artificial intelligence has become one of the key weapons in the fight against cancer and the many forms and mutations that it takes, and today a startup is coming out of stealth and announcing ...

An initial report of the AI technology was presented at the Sixth American Association for Cancer Research (AACR) and the International Association for the Study of Lung Cancer (IASLC) International ...

BURLINGAME, Calif.--(BUSINESS WIRE)-- NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company and NantOmics, LLC, the leader in molecular analysis, today ...